AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
55.41
-1.87 (-3.26%)
Mar 6, 2026, 4:00 PM EST - Market closed
AnaptysBio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 234.6 | 91.28 | 17.16 | 10.29 | 63.18 | Upgrade
|
| Revenue Growth (YoY) | 157.01% | 432.03% | 66.78% | -83.72% | -15.77% | Upgrade
|
| Cost of Revenue | 135.97 | 163.84 | 132.28 | 88.8 | 98.5 | Upgrade
|
| Gross Profit | 98.63 | -72.56 | -115.13 | -78.51 | -35.32 | Upgrade
|
| Selling, General & Admin | 50.74 | 42.39 | 41.95 | 36.64 | 21.49 | Upgrade
|
| Operating Expenses | 50.74 | 42.39 | 41.95 | 36.64 | 21.49 | Upgrade
|
| Operating Income | 47.9 | -114.95 | -157.07 | -115.15 | -56.81 | Upgrade
|
| Interest Expense | -79.89 | -50.09 | -18.08 | -21.11 | -1.45 | Upgrade
|
| Interest & Investment Income | 13.5 | 19.79 | 18.87 | 7.55 | 0.43 | Upgrade
|
| Currency Exchange Gain (Loss) | 5.43 | 0.01 | -0 | 0.01 | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 0.04 | Upgrade
|
| EBT Excluding Unusual Items | -13.07 | -145.23 | -156.28 | -128.7 | -57.8 | Upgrade
|
| Pretax Income | -13.07 | -145.23 | -163.62 | -128.7 | -57.8 | Upgrade
|
| Income Tax Expense | 0.16 | 0 | -0 | 0.02 | - | Upgrade
|
| Net Income | -13.23 | -145.23 | -163.62 | -128.72 | -57.8 | Upgrade
|
| Net Income to Common | -13.23 | -145.23 | -163.62 | -128.72 | -57.8 | Upgrade
|
| Shares Outstanding (Basic) | 29 | 28 | 27 | 28 | 27 | Upgrade
|
| Shares Outstanding (Diluted) | 29 | 28 | 27 | 28 | 27 | Upgrade
|
| Shares Change (YoY) | 1.32% | 5.42% | -4.41% | 2.68% | 0.47% | Upgrade
|
| EPS (Basic) | -0.46 | -5.12 | -6.08 | -4.57 | -2.11 | Upgrade
|
| EPS (Diluted) | -0.46 | -5.12 | -6.08 | -4.57 | -2.11 | Upgrade
|
| Free Cash Flow | 19.61 | -135.7 | -121.61 | -73.95 | -47.29 | Upgrade
|
| Free Cash Flow Per Share | 0.68 | -4.78 | -4.52 | -2.63 | -1.72 | Upgrade
|
| Gross Margin | 42.04% | -79.49% | - | - | -55.91% | Upgrade
|
| Operating Margin | 20.42% | -125.93% | -915.50% | -1119.41% | -89.93% | Upgrade
|
| Profit Margin | -5.64% | -159.11% | -953.66% | -1251.33% | -91.49% | Upgrade
|
| Free Cash Flow Margin | 8.36% | -148.66% | -708.79% | -718.88% | -74.85% | Upgrade
|
| EBITDA | 48.46 | -114.34 | -156.42 | -114.48 | -56.2 | Upgrade
|
| EBITDA Margin | 20.65% | -125.27% | - | - | -88.95% | Upgrade
|
| D&A For EBITDA | 0.56 | 0.61 | 0.65 | 0.68 | 0.62 | Upgrade
|
| EBIT | 47.9 | -114.95 | -157.07 | -115.15 | -56.81 | Upgrade
|
| EBIT Margin | 20.42% | -125.93% | - | - | -89.93% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.